Drug Type Antibody fusion proteins |
Synonyms- |
Mechanism IL-2Rβγ agonists(Interleukin-2 Rβγ agonists), IL15Rβγc modulators, PD-1 modulators(Programmed cell death protein 1 modulators) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |